Yale scientists probe Ketamine's Suicide-Fighting secret
NCT ID NCT05786066
First seen May 18, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study looks at how ketamine reduces suicidal thoughts in people with depression, bipolar disorder, or PTSD. Researchers want to see if blocking a specific brain receptor (AMPA) stops ketamine from working. 30 adults with current suicidal thoughts will receive ketamine with either a placebo or a drug that blocks AMPA receptors. The goal is to understand the brain mechanism, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Connecticut Healthcare System
RECRUITINGWest Haven, Connecticut, 06516, United States
Conditions
Explore the condition pages connected to this study.